Papillary RCC |
Anti-c-Met CAR-T cells |
Cell lines and mouse models |
Anti-c-Met CAR-T cells significantly inhibited tumor growth. |
J. I. Mori et al. (53) |
RCC |
Honokiol and Rapamycin |
Cell lines and mouse models |
The combination of rapamycin and honokiol can effectively down-regulate the phosphorylation of Akt induced by c-Met in RCC cells, significantly inhibit tumor cell proliferation. |
A. Sabarwal et al. (54) |
RCC |
Piperlongumine |
Cell lines |
PL inhibits tumor progression by rapidly reducing c-Met protein and RNA levels. |
K. Golovine et al. (55) |
RCC |
Axitinib and crizotinib |
Mouse models |
The combination of axitinib and crizotinib also significantly enhanced the antitumor efficacy. |
E. Ciamporcero et al. (56) |
PCa |
foretinib (GSK1363089) |
Cell lines |
Fretinib inhibits PCa cell metastasis by promoting the reversal of EMT. |
B. Yin, et al. (40) |
PCa |
2,3,5,6-Tetrahydrobenzo[d]thiazole Derivatives |
Cell lines |
It showed high tumor suppressive activity. |
R. M. Mohareb et al. (57) |
PCa |
PHA665752/Olaparib |
Cell lines |
Combination therapy has a synergistic effect on the growth inhibition of PCa cell lines. |
Z. Wang et al. (58) |
PCa with bone metastasis |
cabozantinib |
Cell lines and mouse models |
Cabozantinib inhibited the growth of intraosseous tumors, decreased tumor-induced osteolysis. |
C. Lee et al. (59) |
PCa |
Heteronemin |
Cell lines |
Heteronemin can effectively antagonize HGF/c-Met/STAT3 activation and tumor proliferation in refractory PCa cells. |
J. C. Wu et al. (60) |
PCa with bone metastasis |
Axitinib and crizotinib |
Mouse models |
The combination of axitinib and crizotinib can significantly inhibit the bone damage of tumor cells, thereby significantly reducing osteoblastic and osteolytic lesions. |
J. Eswaraka et al. (61) |
PCa |
SU11274 |
Cell lines |
The inhibition of c-Met by SU11274 can significantly inhibit the survival and proliferation of tumor cells and enhance their radiosensitivity. |
H. Yu et al. (62) |
PCa |
BMS-777607 |
Cell lines |
BMS-777607 treatment significantly inhibited the proliferation, clonality, migration and invasion of PCa cells. |
Y. Dai et al. (63) |
PCa |
Evodiamine |
Cell lines |
By inhibiting the activation of c-Met/Src/STAT3 signaling axis, it can inhibit the survival, proliferation and angiogenesis of tumor cells. |
S. T. Hwang et al. (64) |
PCa |
Quercetin |
Cell lines |
Quercetin can reverse doxorubicin resistance in PCa cells by down-regulating c-Met expression. |
Y. Shu et al. (65) |
PCa |
Curcumin |
Cell lines |
Curcumin can reverse HGF-induced EMT. |
H. J. Hu et al. (66) |
PCa |
HGF RabMAb |
Mouse models |
Anti-HGF RabMAb not only inhibited the growth of tumor cells, but also inhibited the HGF-dependent proliferation of tumor cells. |
Y. Yu et al. (67) |